<SEC-DOCUMENT>0001000275-24-000103.txt : 20241002
<SEC-HEADER>0001000275-24-000103.hdr.sgml : 20241002
<ACCEPTANCE-DATETIME>20241002143446
ACCESSION NUMBER:		0001000275-24-000103
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241002
DATE AS OF CHANGE:		20241002

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apogee Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001974640
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				934958665
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-41740
		FILM NUMBER:		241346571

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		650-394-5230

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Apogee Therapeutics, LLC
		DATE OF NAME CHANGE:	20230420

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HENDERSON MICHAEL THOMAS
		CENTRAL INDEX KEY:			0001779990
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		421 KIPLING STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001779990</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001974640</issuerCik>
      <issuerName>Apogee Therapeutics, Inc.</issuerName>
      <secFileNumber>001-41740</secFileNumber>
      <issuerAddress>
        <com:street1>221 CRESCENT ST.</com:street1>
        <com:street2>BUILDING 17, SUITE 102B</com:street2>
        <com:city>WALTHAM</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02453</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>650-394-5230</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>HENDERSON MICHAEL THOMAS</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>RBC WEALTH MANAGEMENT</name>
        <address>
          <com:street1>250 NICOLLET MALL, SUITE 1700</com:street1>
          <com:city>MINNEAPOLIS</com:city>
          <com:stateOrCountry>MN</com:stateOrCountry>
          <com:zipCode>55401</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>40000</noOfUnitsSold>
      <aggregateMarketValue>2249176.00</aggregateMarketValue>
      <noOfUnitsOutstanding>58546027</noOfUnitsOutstanding>
      <approxSaleDate>10/02/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>05/22/2022</acquiredDate>
      <natureOfAcquisitionTransaction>INCENTIVE UNIT CONVERSION</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>40000</amountOfSecuritiesAcquired>
      <paymentDate>05/22/2022</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>MICHAEL HENDERSON</name>
        <address>
          <com:street1>4147 26TH STREET</com:street1>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94131</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>APOGEE THERAPEUTICS INCORPORATED</securitiesClassTitle>
      <saleDate>07/05/2024</saleDate>
      <amountOfSecuritiesSold>15000</amountOfSecuritiesSold>
      <grossProceeds>558915.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>MICHAEL HENDERSON </name>
        <address>
          <com:street1>4147 26TH STREET</com:street1>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94131</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>APOGEE THERAPEUTICS INCORPORATED</securitiesClassTitle>
      <saleDate>08/07/2024</saleDate>
      <amountOfSecuritiesSold>40000</amountOfSecuritiesSold>
      <grossProceeds>1624784.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>MICHAEL HENDERSON</name>
        <address>
          <com:street1>4147 26TH STREET</com:street1>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94131</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>APOGEE THERAPEUTICS INCORPORATED</securitiesClassTitle>
      <saleDate>09/04/2024</saleDate>
      <amountOfSecuritiesSold>40000</amountOfSecuritiesSold>
      <grossProceeds>1904848.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>SOLD PURSUANT TO A RULE 10B5-1 PLAN ESTABLISHED 09/25/2023</remarks>
    <noticeSignature>
      <noticeDate>10/02/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>09/25/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>POA / JEFFREY EISCHENS</signature>
    </noticeSignature>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
